TRIB - Trinity Biotech plc

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 559.73M
Enterprise Value 3112.79M
Trailing P/E N/A
Forward P/E 16.34
PEG Ratio (5 yr expected) 10.58
Price/Sales (ttm)0.62
Price/Book (mrq)1.35
Enterprise Value/Revenue 31.16
Enterprise Value/EBITDA 611.09

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin -22.76%
Operating Margin (ttm)6.89%

Management Effectiveness

Return on Assets (ttm)2.43%
Return on Equity (ttm)-40.44%

Income Statement

Revenue (ttm)97.03M
Revenue Per Share (ttm)4.64
Quarterly Revenue Growth (yoy)-0.10%
Gross Profit (ttm)41.45M
EBITDA 10.17M
Net Income Avi to Common (ttm)-22.09M
Diluted EPS (ttm)-1.0570
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)30.28M
Total Cash Per Share (mrq)1.45
Total Debt (mrq)81.62M
Total Debt/Equity (mrq)185.27
Current Ratio (mrq)4.92
Book Value Per Share (mrq)2.11

Cash Flow Statement

Operating Cash Flow (ttm)6.93M
Levered Free Cash Flow (ttm)-19.19M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.21
52-Week Change 3-39.63%
S&P500 52-Week Change 38.79%
52 Week High 35.2500
52 Week Low 32.1300
50-Day Moving Average 32.9056
200-Day Moving Average 32.8888

Share Statistics

Avg Vol (3 month) 345.64k
Avg Vol (10 day) 3114.76k
Shares Outstanding 520.93M
Float 16.98M
% Held by Insiders 115.07%
% Held by Institutions 153.66%
Shares Short (Mar 29, 2019) 4292.76k
Short Ratio (Mar 29, 2019) 45.83
Short % of Float (Mar 29, 2019) 4N/A
Short % of Shares Outstanding (Mar 29, 2019) 4N/A
Shares Short (prior month Feb 28, 2019) 4314.5k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 1, 2015
Ex-Dividend Date 4Jun 5, 2015
Last Split Factor (new per old) 24/1
Last Split Date 3Jun 2, 2005